1. The ethnomedicinal and functional uses, phytochemical and pharmacology of compounds from Ardisia species: An updated review
- Author
-
Bingrui Liu, Rongyu Liu, Qifeng Liu, Charles R. Ashby, Hang Zhang, and Zhe‐Sheng Chen
- Subjects
Pharmacology ,Plants, Medicinal ,Plant Extracts ,Phytochemicals ,Drug Discovery ,Humans ,Molecular Medicine ,Medicine, Traditional ,Ardisia - Abstract
Medicinal plants are considered to be a critical source of novel compounds and pharmacophores. The genus Ardisia, consisting of approximately 500 species, is the largest genus in the Myrsinaceae family. Ardisia species are widely distributed throughout tropical and subtropical regions of the world and have been used for the treatment of cancer, hypertension, irregular menstruation, gonorrhea, diarrhea and postnatal syndromes, among others. Phytochemical studies of Ardisia species have resulted in the isolation and identification of 111 compounds, including triterpenoid saponins, quinones, phenols, coumarins, cyclic depsipepetide and flavonoids. Crude extracts and isolates from Ardisia have been reported to have in vitro and in vivo efficacies, including but not limited to anticancer, antiinflammatory, antimicrobial, antioxidant, antithrombotic and antidiabetic, antitubercular compounds. This review focuses on the medical and functional uses, phytochemical profile and pharmacological efficacies of Ardisia species over the past 15 years. This review will provide information indicating that Ardisia species represent an invaluable source of potential therapeutic compounds.
- Published
- 2022
- Full Text
- View/download PDF